Evidence map›Paper›PMID 41709994›Full record

ArticleCureus2026

Gliosarcoma: A Case Series and Comprehensive Literature Review.

Harvey Misael Aguilar Mora, Laura Karina Barrera Roman, Gervith Reyes Soto, Carlos Castillo-Rangel, Josue Gabriel Agis Ocaña, Manuel Encarnacion Ramirez, Ruben Acosta Garcés

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Harvey Misael Aguilar MoraDepartment of Neurosurgery, Hospital Juárez de México, Mexico City, MEX.
Laura Karina Barrera RomanDepartment of Oncology, Instituto Nacional de Perinatología, Mexico City, MEX.
Gervith Reyes SotoDepartment of Neurosurgical Oncology, Mexico National Cancer Institute, Tlalpan, MEX.
Carlos Castillo-RangelDepartment of Neurosurgery, Servicie of the 1ro de Octubre Hospital of the ISSSTE, Mexico City, MEX.
Josue Gabriel Agis OcañaDepartment of Pathology, Hospital Juárez de México, Mexico City, MEX.
Manuel Encarnacion RamirezDepartment of Neurosurgery, Peoples' Friendship University of Russia (RUDN University), Moscow, RUS.
Ruben Acosta GarcésDepartment of Neurosurgery, Hospital Juárez de México, Mexico City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gliosarcoma represents an uncommon primary neoplasm of the central nervous system, distinguished by a biphasic histological architecture that combines glial and mesenchymal elements. In this report, we present three cases of intracranial tumors confirmed histopathologically as gliosarcoma, offering a comprehensive account of their clinical presentation, neuroimaging characteristics, and pathological features. The lesions involved different cerebral regions, specifically the frontal, temporal, and occipital lobes, and manifested with a heterogeneous range of symptoms, including headache, focal motor weakness, and epileptic seizures. The series comprises two male patients and one female patient, aged 54, 51, and 63 years. All patients underwent surgical resection, followed by adjuvant radiotherapy with concurrent and/or adjuvant temozolomide. Despite multimodal treatment, disease progression occurred, consistent with the aggressive biological behavior of gliosarcoma, which is associated with a reported median overall survival of approximately 13-16 months. Through detailed analysis of each case, we highlight the key clinical, radiological, and histopathological findings, emphasizing their diagnostic value and the importance of integrating treatment and outcome data to contextualize prognosis in this rare tumor entity.

Indexed as

astrocytic neoplasmsbiphasic tumorcentral nervous system tumorsgliosarcomaneurosurgical oncology

Identifiers

PMID41709994
PMCPMC12911531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.